Data shows Glaxo drug works against Omicron mutations
Research shows Glaxo’s Covid-19 antibody treatment is effective against the full combination of mutations in the new variant....
Search
African Pharma Review
- 2 days ago
- 1 min
Merck announces pause in enrolment for Phase 3 HIV PreP studies
Additional monitoring measures for study participants, have been recommended by the external Data Monitoring Committee. Merck, which is...
African Pharma Review
- Dec 1
- 1 min
Aspen Pharmacare to make its own COVID-19 vaccine brand
Amid fourth wave concerns fuelled by the Omicron variant, local pharma company Aspen signs historic deal. South African pharmaceutical...
African Pharma Review
- Nov 30
- 1 min
Pfizer is working on a vaccine to target Omicron
The current vaccine is being tested against the Omicron variant, which was initially reported in South Africa. Pfizer has already started...
African Pharma Review
- Nov 26
- 1 min
Merck halts development of MK-8507 after release of mid-stage study data
Dosing and development of the MK-8507 drug has been paused with further review of islatravir studies. Months after talking up it’s...
%20(2).png)
